[1]
M. Ruggeri, A. Cicchetti, S. Coretti, C. Cammà, N. Caporaso, and A. Gasbarrini, “A new decision model for economic evaluation of novel therapies for HCV”, FE, vol. 15, no. 3, Sep. 2014.